Feb 16, 2014 · The EHRA classification, as originally proposed, is a valid means of quantifying AF symptom severity and correlates well with AFEQT and with the generic EQ-5D.

The EHRA score has been validated as a semi-quantitative measure of AF related symptoms and patients' perception of their general state of health. A simple modification of the EHRA score (the mEHRA score) provides better discrimination for patients with mild to moderate symptoms.

Welcome to the page that accompanies the EHRA Practical Guide on the use of novel oral anticoagulant drugs (NOACs) in patients with non-valvular atrial fibrillation (AF).

Atrial fibrillation (AF) is one of the major common and chronic disorders in modern cardiology. There are exciting new developments in several areas of AF management that carry the hope of improving outcomes in AF patients.

Aug 30, 2024 · ESC Clinical Practice Guidelines aim to present all the relevant evidence to help physicians weigh the benefits and risks of a particular diagnostic or therapeutic procedure on Atrial Fibrillation. They should be essential in everyday clinical decision making.

Mar 28, 2014 · Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and ...

Aug 9, 2020 · Different studies define “asymptomatic AF” as AF diagnosed incidentally or by ECG in patients reporting no symptoms, or, alternatively, with European Heart Rhythm Association (EHRA) score 1 [6,7,8,9,10,12]. Other studies [6,7,10] consider silent …

AF: Atrial Fibrillation; a: EHRA IIa and IIb can be distinguished by assessing whether AF symptoms affect the patient's function. The most common AF-related symptoms are fatigue/exhaustion, exertional dyspnea, or less commonly, palpitations and chest pain.

Jan 1, 2018 · A simple symptom score (EHRA score) has been recommended recently to quantify AF-related symptoms. It considers symptoms that are attributable to AF and reverse or reduce upon restoration of sinus rhythm or with effective rate control (1).

Aims: To validate the European Heart Rhythm Association (EHRA) symptom classification in atrial fibrillation (AF) and test whether its discriminative ability could be improved by a simple modification.